Background
• Novel and complex model types are being used more regularly in economic evaluations. However, it is not yet clear how these are received by Evidence Review Groups (ERGs).
• Knowledge of common criticisms relating to specific types of model could be invaluable to those involved in developing economic models for Health Technology Assessment (HTA) submissions.
Methods
• All National Institute of Health and Care Excellence (NICE) single technology appraisals published between May 2016 and May 2017 were reviewed.
• Data extracted included indication, model type, the program used for model development, whether the ERG considered the model type appropriate, and details of the ERG critique.
• Cancer Drugs Fund rapid reconsiderations, multiple technology appraisals, and appraisals which had been subsequently replaced or updated were excluded from the analysis, in order to focus on the most recent novel models submitted by companies.
• When the ERG considered the model structure to be appropriate for the decision problem, this was assumed to also apply to model type.
Results
• The 48 submissions reviewed included 43 cohort statetransition models (Markov, partitioned survival, semiMarkov and decision tree/Markov models), 1 Markov model run as both a cohort and microsimulation model, 3 Monte Carlo individual patient simulations (IPS) and 1 Discretely Integrated Condition Event (DICE) model ( Figure 1 ).
-Of the 35 (72.9%) submissions which stated the program used to build the model, almost all used Excel. Only 1 was built in another program (C++), and this resulted in the ERG being unable to check the model implementation.
• In 27 (56.3%) submissions, 14 of which were partitioned survival models in oncology indications, the ERG agreed the model type was appropriate, typically due to alignment with previous models in the same indication or in similar indications.
• In 12 (25.0%) submissions, the ERG critique of the model type was unclear or not stated.
• In the remaining 9 (18.8%) submissions, the ERG was unsatisfied with the model type to some extent:
-In 2 of these cases, a dynamic modelling approach was considered more appropriate than a Markov model (in infectious diseases), 1, 2 and in 2 other cases, patient heterogeneity was believed to be important where a cohort model had been used. 3, 4 -A total of 6 models were criticised for inflexibility in capturing key evidence (2 partitioned survival models), 5, 6 or for unnecessary complexity and lack of transparency (2 Markov, 1 DICE and 1 partitioned survival model).
1, 5-9 -Furthermore, the DICE model was criticised for impractical implementation and lack of clear benefit over a Discrete Event Simulation (DES) model. 
Conclusions
• In the majority of cases, ERGs include an explicit review of model type in their critique.
• Cohort state-transition models are generally considered appropriate by ERGs, with the justification that they have previously been used in the disease area.
• Other model types are more common in disease areas with fewer submissions, and are generally considered appropriate if their implementation is transparent and user-friendly.
• Practical implementation with reasonable model run times is an important factor when considering new model types such as DICE and DES. 
